Senzime for investors

Senzime develops, manufactures and markets CE- and FDA-cleared patient monitoring systems. The goal is to help eliminate in-hospital complications, and radically reduce healthcare costs related to surgical and high acuity procedures.

Presentation of Q1 2023 report

Go to recording

Presentation in PDF

Annual and sustainability report 2022

Annual General meeting 2023

The Annual General Meeting of Senzime AB was held on Tuesday, May 16, 2023, in Uppsala, Sweden.

Contact us

Want to know more?

How can Senzime’s innovative patient monitoring solutions help to eliminate in-hospital complications?
Contact us today.